Jeffrey B. Halldorson, M.D.
Patient Services:Kidney and kidney / pancreas Post-transplant: Living Kidney Donor Program Liver transplant Post-transplant: Academic Office:Phone: 206-598-6263 E-mail: Fax: 206-598-0628 Address: |
Assistant Professor
Faculty Appointment:
University of Washington, Clinical Assistant Professor, 2007 - present.
University of Washington, Acting Assistant Professor, 2003 - 2007.
Education:
Fellowships: University of California, San Francisco, Transplantation, 2001-03.
University of Pennsylvania, Molecular Biology/Gene Therapy, 1995-99.
Residency: University of Minnesota, 1993-2001.
Internship: University of Minnesota, 1992-93.
M.D. Degree: University of Michigan, 1992.
Board Certified: General Surgery, 2003.
Clinical Interests:
Liver, kidney and pancreas transplantation, hepatobiliary surgery.
Research Interests:
Development of SV40 based vector expression system for gene transfer to kidney, liver, intestine and stem cells.
Selected Publications:
Louboutin JP, Rouger K, Tinsley J, Halldorson J, Wilson J. INOS expression in Dystrophinopathies can be reduced by somatic gene transfer of dystrophin or utrophin. Molecular Medicine, 7(5):355-364, 2001.
Zwacka RM, Zhang Y, Zhou W, Halldorson J, Engelhardt JF. Ischemia /reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor kappa B independently of lkappa B degradation. Hepatology, 28(4):1022-30, 1998.
Zwacka RM, Zhou W, Zhang Y, Darby C, Dudus L, Halldorson J, Oberley L, Engelhardt JF. Redox gene therapy for ischedmia/reperfusion injury of the liver reduces AP-1 and NF-kappa B activation. Nature Medicine, 4(6):698-704, 1998.
reviewed 04/04